EQS — News: NVision Deploys POLARIS at UCLouvain to Advance Cancer Metabolism Research

EQS-News: NVision Quantum / Key word(s): Miscellaneous NVision Deploys POLARIS at UCLouvain to Advance Cancer Metabolism Research 13.10.2026 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. ══════════════════════════════════════════════════════════════════════════ NVision Deploys POLARIS at UCLouvain to Advance Cancer Metabolism Research ● Installation at UCLouvain’s NEST imaging platform will support research into treatment response and resistance in melanoma, triple-negative breast cancer and metastatic disease ULM, Germany and BRUSSELS, Belgium, October 13, 2026 — NVision, a quantum technology company, today announced the deployment of its POLARIS quantum-enhanced MRI platform at UCLouvain’s Nuclear and Electron Spin Technologies (NEST) imaging platform in Belgium. Researchers will use the system to study cancer metabolism in preclinical models of melanoma, triple-negative breast cancer and metastatic disease, with an initial focus on identifying metabolic changes associated with treatment response and resistance. The installation marks the latest expansion of NVision’s growing network of quantum-enhanced MRI research sites. In recent weeks